Drugs Made In America Acquisition (DMII) Long-Term Investments (2025)
Drugs Made In America Acquisition (DMII) posted quarterly Long-Term Investments of $504.9 million for Q4 2025, up 0.96% quarter-over-quarter from $500.1 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Long-Term Investments (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Long-Term Investments for 1 consecutive years, with $504.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Investments changed N/A year-over-year to $504.9 million; the TTM figure through Dec 2025 stood at $504.9 million (changed N/A YoY), while the FY2025 annual figure was $504.9 million, changed N/A from the prior year.
- Long-Term Investments improved to $504.9 million in Q4 2025 per DMII's latest filing, from $500.1 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $504.9 million in Q4 2025 and bottomed at $500.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 260.50 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.51 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 513.88 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.77 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.24 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.40 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 313.51 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.14 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.71 Mn |
| 10 | CSLM Digital Asset Acquisition Corp III | 322.52 Mn | 314.90 Mn | - | 237.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.93 Mn |
| Sep 30, 2025 | 500.11 Mn |